ProQR Therapeutics N.V.
PRQR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001612940
In the last 90 days, ProQR Therapeutics N.V. insiders filed 4 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding ProQR Therapeutics N.V. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 77 | 65 | −12 |
| Shares | 44.4M | 41.3M | −3.12M (−7.0%) |
| Value | $117.7M | $54.9M | −$62.8M (−53.3%) |
New holders (7)
Institutions that held ProQR Therapeutics N.V. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Standard Life Aberdeen plc | 1,850,348 | $2.46M | 0.00% |
| Persistent Asset Partners Ltd | 47,783 | $63.6K | 0.06% |
| Vontobel Holding Ltd. | 36,257 | $48.2K | 0.00% |
| Quadrature Capital Ltd | 26,403 | $35.4K | 0.00% |
| Gsa Capital Partners LLP | 14,683 | $20.0K | 0.00% |
| Flaharty Asset Management, LLC | 2,000 | $2.66K | 0.00% |
| Activest Wealth Management | 100 | $133 | 0.00% |
Sold out (19)
Institutions that held ProQR Therapeutics N.V. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Altium Capital Management LP | 575,000 | $1.52M |
| UBS Oconnor LLC | 227,020 | $601.6K |
| M&T Bank Corp | 124,770 | $330.3K |
| Susquehanna International Group, LLP | 67,054 | $177.7K |
| Marshall Wace, LLP | 59,515 | $157.7K |
| Virtu Financial LLC | 31,158 | $83.0K |
| Prudential Financial Inc | 27,600 | $73.1K |
| Jump Financial, LLC | 26,702 | $70.8K |
| Ballentine Partners, LLC | 23,035 | $61.0K |
| Two Sigma Securities, LLC | 15,116 | $40.1K |
| Alpine Global Management, LLC | 14,749 | $39.1K |
| Engineers Gate Manager LP | 14,580 | $38.6K |
| Signaturefd, LLC | 5,824 | $15.4K |
| Quadrant Capital Group LLC | 5,488 | $14.5K |
| Tower Research Capital LLC (TRC) | 3,632 | $9.63K |
| US Bancorp | 2,214 | $5.87K |
| Lindbrook Capital, LLC | 2,135 | $5.66K |
| Concord Wealth Partners | 444 | $1.18K |
| Lazard Asset Management LLC | 103 | $0 |